Influence of intrinsic radiosensitivity on the survival of breast cancer patients.

2.50
Hdl Handle:
http://hdl.handle.net/10541/79133
Title:
Influence of intrinsic radiosensitivity on the survival of breast cancer patients.
Authors:
Roberts, Stephen A; Levine, Edward; Scott, David
Abstract:
PURPOSE: The association between enhanced intrinsic radiosensitivity, measured by the level of chromosome damage induced in either the G2 or G0 phases of the cell cycle, and the risk of breast cancer has been well demonstrated. Although not originally designed for this purpose, early studies are now sufficiently mature (median follow-up 4.2 years) to enable an assessment of the impact of radiosensitivity on patient outcome. MATERIALS AND METHODS: Breast cancer patients assessed in previous studies of G2 and G0 lymphocyte chromosomal radiosensitivity between 1993 and 1997 were identified. Tumour characteristics, recurrence and survival data were obtained from clinical records and outcomes were compared between those identified as having normal and elevated radiosensitivity in the two assays. RESULTS: There was a significant association between G0 sensitivity and tumour grade (p=0.03), but otherwise there were no associations in these series between radiosensitivity in the two assays and tumour characteristics. Overall survival in this cohort of patients was high (94% at 5 years) and there was no association between the G2 or G0 assay results and outcome as measured by cancer-specific survival or local recurrence. CONCLUSIONS: Radiosensitivity, as measured by these two assays, was not a strong prognostic factor following standard radiotherapy treatment. However, the statistical power of the present study was limited and modest prognostic utility could not be discounted. Further studies designed specially to investigate outcome are needed, possibly in association with trials of altered radiotherapy fractionation.
Affiliation:
Biostatistics Group, School of Epidemiology and Health Sciences, University of Manchester, Manchester M13 9PT, UK. steve.roberts@man.ac.uk
Citation:
Influence of intrinsic radiosensitivity on the survival of breast cancer patients. 2003, 79 (5):311-7 Int. J. Radiat. Biol.
Journal:
International Journal of Radiation Biology
Issue Date:
May-2003
URI:
http://hdl.handle.net/10541/79133
DOI:
10.1080/0955300031000137797
PubMed ID:
12943239
Type:
Article
Language:
en
ISSN:
0955-3002
Appears in Collections:
All Christie Publications ; All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorRoberts, Stephen A-
dc.contributor.authorLevine, Edward-
dc.contributor.authorScott, David-
dc.date.accessioned2009-08-28T11:49:14Z-
dc.date.available2009-08-28T11:49:14Z-
dc.date.issued2003-05-
dc.identifier.citationInfluence of intrinsic radiosensitivity on the survival of breast cancer patients. 2003, 79 (5):311-7 Int. J. Radiat. Biol.en
dc.identifier.issn0955-3002-
dc.identifier.pmid12943239-
dc.identifier.doi10.1080/0955300031000137797-
dc.identifier.urihttp://hdl.handle.net/10541/79133-
dc.description.abstractPURPOSE: The association between enhanced intrinsic radiosensitivity, measured by the level of chromosome damage induced in either the G2 or G0 phases of the cell cycle, and the risk of breast cancer has been well demonstrated. Although not originally designed for this purpose, early studies are now sufficiently mature (median follow-up 4.2 years) to enable an assessment of the impact of radiosensitivity on patient outcome. MATERIALS AND METHODS: Breast cancer patients assessed in previous studies of G2 and G0 lymphocyte chromosomal radiosensitivity between 1993 and 1997 were identified. Tumour characteristics, recurrence and survival data were obtained from clinical records and outcomes were compared between those identified as having normal and elevated radiosensitivity in the two assays. RESULTS: There was a significant association between G0 sensitivity and tumour grade (p=0.03), but otherwise there were no associations in these series between radiosensitivity in the two assays and tumour characteristics. Overall survival in this cohort of patients was high (94% at 5 years) and there was no association between the G2 or G0 assay results and outcome as measured by cancer-specific survival or local recurrence. CONCLUSIONS: Radiosensitivity, as measured by these two assays, was not a strong prognostic factor following standard radiotherapy treatment. However, the statistical power of the present study was limited and modest prognostic utility could not be discounted. Further studies designed specially to investigate outcome are needed, possibly in association with trials of altered radiotherapy fractionation.en
dc.language.isoenen
dc.subjectBreast Canceren
dc.subject.meshAged-
dc.subject.meshBreast Neoplasms-
dc.subject.meshChromosome Aberrations-
dc.subject.meshCohort Studies-
dc.subject.meshFemale-
dc.subject.meshG0 Phase-
dc.subject.meshG2 Phase-
dc.subject.meshHumans-
dc.subject.meshLymphocytes-
dc.subject.meshMiddle Aged-
dc.subject.meshPrognosis-
dc.subject.meshRadiation Tolerance-
dc.subject.meshSurvival Rate-
dc.titleInfluence of intrinsic radiosensitivity on the survival of breast cancer patients.en
dc.typeArticleen
dc.contributor.departmentBiostatistics Group, School of Epidemiology and Health Sciences, University of Manchester, Manchester M13 9PT, UK. steve.roberts@man.ac.uken
dc.identifier.journalInternational Journal of Radiation Biologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.